DRD2 rs2734839: Understanding This Schizophrenia-Linked Variant
The rs2734839 variant is a single-nucleotide polymorphism located within the DRD2 gene, which encodes a critical dopamine receptor in the brain. Research has identified associations between this specific genetic variation and both the risk of developing schizophrenia and the potential age of symptom onset.
What each genotype means
Baseline risk profile
This genotype represents the common genetic state at this position in the DRD2 gene. Research indicates that individuals without the risk-associated allele may have a different statistical likelihood for schizophrenia onset compared to carriers of the G allele.
This is a common genotype found across most global populations.
Potential risk indicator
Carrying one copy of the G allele has been associated in some studies with an increased statistical likelihood of schizophrenia and may influence the age of symptom onset. Because this association is based on limited evidence, it should not be used to predict individual health outcomes or diagnose conditions.
This heterozygous genotype is observed at varying frequencies depending on ancestral background.
Elevated risk indicator
Some research suggests that individuals carrying two copies of the G allele may have a higher statistical association with schizophrenia risk and potential variations in age of onset compared to those without the variant. These findings are based on limited psychiatric genetics cohorts and do not constitute a medical diagnosis.
This genotype is less common than the A/A state and varies significantly by population ancestry.
What is rs2734839 and Where is it Located?
The variant rs2734839 is a single-nucleotide polymorphism (SNP) situated on chromosome 11 within the DRD2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific marker was identified through haplotype block-based gene-tagging approaches, which allow researchers to represent the genetic diversity of an entire gene using a select number of representative SNPs. By studying rs2734839, scientists aim to understand how variations in this specific region of the genome might influence biological processes. Because it sits within the DRD2 locus, it is frequently investigated in the context of psychiatric genetics, where researchers look for patterns that correlate with specific behavioral or clinical outcomes. It is important to note that while this SNP is a useful marker for study, it is one of many variations within the complex DRD2 gene, and its presence does not function in isolation.
The Role of the DRD2 Gene
The DRD2 gene provides instructions for creating the D2 subtype of the dopamine receptor. This receptor is a G-protein coupled receptor, a type of protein that sits on the surface of cells and transmits signals from the outside to the inside. Dopamine is a neurotransmitter, a chemical messenger that plays a vital role in reward, motivation, memory, and motor control. By inhibiting adenylyl cyclase activity, the D2 receptor helps regulate the flow of dopamine signals in the brain, particularly in areas like the basal ganglia. Because dopamine signaling is central to many neurological and psychiatric functions, the DRD2 gene is a primary target for many psychotropic medications, including antipsychotics. Dysregulation of this system is a widely accepted model for understanding the pathophysiology of various conditions, making the DRD2 gene a focal point for researchers investigating the biological underpinnings of mental health disorders.
Research Associations and Evidence Strength
Scientific literature has explored the link between rs2734839 and schizophrenia. One study utilizing a multiplex mass spectrometry method found that individuals carrying specific variations at this site were more than twice as likely to have a schizophrenia diagnosis compared to control groups. Furthermore, this research suggested that the variant might act as a predictor for the age of onset, with some genotypes showing a correlation with a later onset of symptoms. However, it is crucial to recognize that the evidence strength for this specific SNP remains limited. While some studies have reported significant associations, psychiatric genetics is a complex field where many genes and environmental factors interact. The findings regarding rs2734839 are considered preliminary indicators rather than definitive diagnostic tools. As with many genetic markers in psychiatry, these associations require further replication in larger, diverse cohorts to fully understand their clinical relevance and biological impact.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs2734839 is primarily intended for educational and research purposes. It is vital to understand that having a specific genotype does not constitute a medical diagnosis, nor does it guarantee the development of any condition. Schizophrenia is a multifactorial disorder influenced by a combination of genetic, environmental, and developmental factors. You cannot use this information to predict your personal health future or to make decisions about medical treatment. If you are concerned about your mental health or have questions about psychiatric medications, you must discuss these topics with a qualified clinician or psychiatrist. They are the only ones who can provide a proper evaluation based on your full clinical history. Never alter your medication regimen or make health decisions based on genetic test results without professional medical guidance, as doing so can be dangerous.
How common is this variant?
The rs2734839 variant is commonly studied in psychiatric genetics cohorts, though specific allele frequencies can vary significantly across different global ancestral populations.
Frequently asked questions
Does having the rs2734839 variant mean I will develop schizophrenia?
No. Genetic variants like rs2734839 are associated with statistical risk in large populations, but they do not determine an individual's health outcome. Schizophrenia is a complex condition influenced by many genetic and environmental factors.
Can I use this SNP to predict when I might get sick?
No. While some research has suggested a link between this variant and the age of onset for schizophrenia, this is a statistical observation in research groups. It cannot be used to predict the timing of symptoms for any specific person.
Should I change my medication based on my DRD2 genotype?
Absolutely not. You should never change your medication or dosage based on genetic test results. Always consult with your doctor or pharmacist before making any changes to your prescribed treatment plan.
Where can I find more information about DRD2?
You can find reliable information about the DRD2 gene and its functions through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2734839?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
Linked to variations in reward-seeking behavior and addiction risk.
Influences the density of dopamine receptors and cognitive processing speed.
This variant has been studied for its association with schizophrenia and dopaminergic signaling.
This dopamine receptor D2 variant was investigated as a potential genetic risk factor for endometriosis-related infertility.
This SNP is located in a linkage disequilibrium block of the DRD2 gene and was evaluated for links to endometriosis-related infertility.
Commonly studied variant in the Dopamine D2 Receptor gene linked to cognitive flexibility and processing speed.